Prosus Taps iFood's Fabricio Bloisi as New Chief
By Christian Moess Laursen
Prosus and South African parent Naspers named Fabricio Bloisi as group chief executive, replacing interim boss Ervin Tu, who will become president and chief investment officer.
Bloisi is currently chief executive of iFood, a food-delivery company in Latin America, which he acquired in 2013, Dutch investment group Prosus said Friday.
"Fabricio is a proven entrepreneur and innovator with deep roots in operating, building and scaling world-class technology companies within growth markets," Prosus said.
Bloisi will be taking over in July from interim chief Tu, who has had the reins on an interim basis for the past eight months.
Prosus, the top shareholder of Chinese tech giant Tencent, said its strategic goals remain unchanged.
It is still on track to meet its expectations for the year, including achieving consolidated ecommerce trading profit during the second half-year, and the continuation of its share buyback program, it said.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
May 17, 2024 01:48 ET (05:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
13 Charts On the Market’s Q2 Turnaround
-
10 Top-Performing Dividend Stocks of Q2 2024
-
Markets Brief: US Jobs Report In View as Q3 Begins
-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Energy: OPEC Continues to Operate From a Position of Weakness With Production Cuts Extension
-
Communication Services: Online Advertising Remains Strong, but Growth Will Likely Decelerate
-
3 Stocks to Buy This Summer While They’re Seriously Undervalued
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded